CLINICAL_TRIALS
trial_result
· 2017-07-17
Clinical Trial Update: Safety and Efficacy of AIN457 in Noninfectious Uveitis [Phase 2]
Summary
Phase 2 trial assessing the safety and efficacy of AIN457 (secukinumab) for noninfectious uveitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Non-infectious Uveitis | Phase 2 | Status: COMPLETED | Results posted: 2017-07-17